Methods and compositions for enhancing gene editing
US-2018245065-A1 · Aug 30, 2018 · US
US12325865B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12325865-B2 |
| Application number | US-201816482294-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 31, 2018 |
| Priority date | Feb 1, 2017 |
| Publication date | Jun 10, 2025 |
| Grant date | Jun 10, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides methods of improving nuclease-mediated gene targeting frequencies in cells using PFTα or bFGF.
Opening claim text (preview).
The invention claimed is: 1. A method of making a population of PERV-free porcine cells, the method comprising: (a) genetically modifying a primary porcine cell which comprises porcine endogenous retrovirus (PERV) genes by providing a vector comprising a nucleic acid sequence which encodes a nuclease and three sgRNAs to the primary porcine cell, wherein the nuclease is expressed and cuts the PERV genes, thereby producing a genetically modified, PERV-free, primary porcine cell, (b) providing an exogenous pifithrin α (PFTα) and a basic fibroblast growth factor (bFGF) to the primary porcine cell concomitant with step (a), (c) contacting the primary porcine cell with a large SV40 T antigen to increase targeting efficiency, (d) isolating the genetically modified, PERV-free primary porcine cell, and expanding the genetically modified, PERV-free porcine cell to a population of PERV-free porcine cells, wherein the population of PERV-free porcine cells exhibits a lack of PERV transmission as evidenced by co-culturing a cell with the population of PERV-free porcine cells. 2. The method of claim 1 , wherein the nuclease is a Cas nuclease, a Cas nickase, or a nuclease null Cas bound to a nuclease. 3. The method of claim 2 , wherein the nuclease is the Cas nuclease. 4. The method of claim 3 , wherein the Cas nuclease is Cas9. 5. The method of claim 1 , wherein the PERV genes comprise PERV pol genes. 6. The method of claim 1 , wherein of the PFTα and the bFGF inhibit apoptosis in the primary porcine cell. 7. The method of claim 1 , wherein the PFTα and the bFGF increase gene editing rates in the primary porcine cell. 8. The method of claim 1 , wherein the PFTα and the bFGF increase a cell survival rate in the primary porcine cell.
Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites · CPC title
Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title
involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title
basic FGF [bFGF] · CPC title
General methods applicable to biologically active non-coding nucleic acids · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.